ACTIVE SUBSTANCE / INN

ARGATROBAN

Brand name(s): ARGATROBAN IN DEXTROSE, ARGATROBAN IN SODIUM CHLORIDE, ARGATROBAN IN 0.9% SODIUM CHLORIDE, ARGATROBAN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
NDA022434
NDA201743
ACTIVE SUBSTANCE
Argatroban
REGULATORS
FDA
SPONSORS / MAH
SANDOZ, MYLAN INSTITUTIONAL, CIPLA
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ARGATROBANANDA079238PLIVA HRVATSKA DOONone (Tentative Approval)
ARGATROBANANDA202626MYLAN INSTITUTIONALPrescription
ARGATROBAN IN SODIUM CHLORIDENDA209552EUGIA PHARMA SPECLTSPrescription
ARGATROBAN IN DEXTROSENDA201743SANDOZDiscontinued
ARGATROBAN IN SODIUM CHLORIDENDA022434CIPLADiscontinued
ARGATROBANNDA020883SANDOZDiscontinued
ARGATROBAN IN 0.9% SODIUM CHLORIDENDA206769TEVA PHARMS USADiscontinued

FULL INTELLIGENCE ON ARGATROBAN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →